PHP
EVH icon

Parkman Healthcare Partners’s Evolent Health EVH Stock Holding History

Parkman Healthcare Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-103,320
Closed -$2.81M – 96
2023
Q3 		$2.81M Sell
103,320
-16,172
-14% -$450K 0.52% 58
2023
Q2 		$3.62M Sell
119,492
-67,431
-36% -$2.18M 0.63% 52
2023
Q1 		$6.07M Buy
+186,923
New +$5.91M 1.32% 31

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Parkman Healthcare Partners's EVH Position: Q4 2023 in Review

Parkman Healthcare Partners sold out of Evolent Health (EVH) in Q4 2023, closing a stake of 103,320 shares — an estimated $2.81M sold.

Parkman Healthcare Partners first reported a position in EVH in Q1 2023 and held it in 3 quarters. The position peaked at $6.07M in Q1 2023. 234 funds tracked by Wall St. Rank hold EVH as of Q4 2023.

  • Parkman Healthcare Partners reported no remaining Evolent Health position as of Q4 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 103,320 Evolent Health shares in Q4 2023, an estimated $2.81M.
  • Parkman Healthcare Partners first reported a position in Evolent Health in Q1 2023 and held it in 3 quarters.
  • Parkman Healthcare Partners's Evolent Health position peaked at $6.07M in Q1 2023.
  • 234 funds tracked by Wall St. Rank held Evolent Health as of Q4 2023.

Based on Parkman Healthcare Partners's 13F filing for Q4 2023, filed 14 Feb 2024.